PeptiStar has issued New Shares through Third-Party Allotment and raised 1.79 billion Yen.
We will exhibit & make a presentation at US TIDES (virtual event)
NeuroScientific Biopharmaceuticals(NSB) announced NSB signed on manufacturing service agreement.
NeuroScientific Biopharmaceuticals Ltd. (NSB社)が受委託契約締結を発表
AMED and PeptiStar announced they accomplished the CiCLE project goal, “establishment of a global leading contract manufacturing organization (CMO) for constrained peptide medicines”.